Skip to content

Clinical trials

Phase 3 Immunoblastic Lymphadenopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Phase: Phase 3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20032
20051
20061
20071
20082
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jonsson Comprehensive Cancer Center3
Alliance for Clinical Trials in Oncology2
Memorial Sloan Kettering Cancer Center2
Case Comprehensive Cancer Center1
Corvus Pharmaceuticals, Inc.1
INSYS Therapeutics Inc1
Mayo Clinic1
NCIC Clinical Trials Group1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy13
Lymphoma, Large-Cell, Anaplastic13
Lymphoma, Large B-Cell, Diffuse12
Burkitt Lymphoma11
Hodgkin Disease11
Leukemia, Lymphocytic, Chronic, B-Cell11
Lymphoma, Follicular11
Lymphoma, Large-Cell, Immunoblastic11
Lymphoma, Mantle-Cell11
Lymphoma, Non-Hodgkin11

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.